Rx Drug DTC Advertising: ‘Europe Is A Minefield’ With LinkedIn Posts Triggering Slew Of Complaints

UK body overseeing complaints about pharmaceutical materials has determined that merely liking a post on LinkedIn is promotion. The Prescription Medicines Code of Practice Authority  (PMCPA) has completed review of more than 50 complaints about LinkedIn posts.

Global LinkedIn
UK body objects to 'liking' of LinkedIn posts about prescription drugs • Source: Shutterstock

Pharmaceutical companies have a new worry in ensuring communications about their products do not run afoul of advertising rules in the European Union: posts on LinkedIn.

Dozens of complaints against companies have been submitted to the Prescription Medicines Code of Practice Authority (PMCPA), the self-regulatory body enforcing UK’s advertising

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Marketing & Advertising

More from Compliance